ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,037.88
      0.00%
      US Tech 100
      20,838.80
      -0.67%
      Dow Jones
      44,556.04
      0.00%
      Brent Oil
      75.25
      -0.91%
      Bitcoin
      98,675.61
      0.83%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Sera Prognostics Inc (SERA) Quote

      Sera Prognostics Inc

      Sera Prognostics Inc (SERA)

      NASDAQ
      4.96
      -0.31
      (-5.88%)
      Closed February 04 4:00PM
      Delayed by 15 minutes
      4.96
      0.00
      ( 0.00% )
      Pre Market: 8:24AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      4.96
      Bid
      1.99
      Ask
      5.70
      Volume
      38
      0.00 Day's Range 0.00
      4.6101 52 Week Range 12.355
      Market Cap
      167.512M
      Previous Close
      4.96
      Open
      -
      Last Trade
      35
      @
      4.97
      Last Trade Time
      08:24:18
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      105,984
      Shares Outstanding
      33,772,500
      Dividend Yield
      -
      PE Ratio
      -4.62
      Earnings Per Share (EPS)
      -1.07
      Revenue
      306k
      Net Profit
      -36.24M

      About Sera Prognostics Inc

      Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, and other pregnancy complications. Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, and other pregnancy complications.

      Sector
      Medical Laboratories
      Industry
      Medical Laboratories
      Website
      www.seraprognostics.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Sera Prognostics Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker SERA. The last closing price for Sera Prognostics was $4.96. Over the last year, Sera Prognostics shares have traded in a share price range of $ 4.6101 to $ 12.355.

      Sera Prognostics currently has 33,772,500 shares outstanding. The market capitalization of Sera Prognostics is $167.51 million. Sera Prognostics has a price to earnings ratio (PE ratio) of -4.62.

      Ask ADVFN Intelligence (AI)

      SERA Latest News

      More News

      Form 8-K - Current report

      January 31 2025
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      January 27 2025
      Edgar (US Regulatory)

      Sera Prognostics to Host Virtual R&D Day on January 31

      Sera Prognostics to Host Virtual R&D Day on January 31 PR Newswire SALT LAKE CITY, Jan. 27, 2025 Event will showcase results of Company's pivotal PRIME study and include the principal...

      January 27 2025
      PR Newswire (US)

      Form 4 - Statement of changes in beneficial ownership of securities

      January 14 2025
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      January 14 2025
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      January 14 2025
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      January 14 2025
      Edgar (US Regulatory)

      Form 8-K - Current report

      January 13 2025
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      January 10 2025
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      January 10 2025
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-1.21-19.61102106976.176.91754.61011056985.6545225CS
      4-3.0085-37.7549099587.96858.734.61011043466.3933647CS
      12-2.42-32.79132791337.389.12974.61011059847.30579313CS
      26-2.04-29.142857142979.12974.6101996257.38519181CS
      52-2.65-34.82260183977.6112.3554.61011522907.92569596CS
      156-2.04-29.1428571429712.3551.13232044.56368125CS
      260-10.05-66.955363091315.0115.51.12840594.8148338CS

      SERA - Frequently Asked Questions (FAQ)

      What is the current Sera Prognostics share price?
      The current share price of Sera Prognostics is $ 4.96
      How many Sera Prognostics shares are in issue?
      Sera Prognostics has 33,772,500 shares in issue
      What is the market cap of Sera Prognostics?
      The market capitalisation of Sera Prognostics is USD 167.51M
      What is the 1 year trading range for Sera Prognostics share price?
      Sera Prognostics has traded in the range of $ 4.6101 to $ 12.355 during the past year
      What is the PE ratio of Sera Prognostics?
      The price to earnings ratio of Sera Prognostics is -4.62
      What is the cash to sales ratio of Sera Prognostics?
      The cash to sales ratio of Sera Prognostics is 545.05
      What is the reporting currency for Sera Prognostics?
      Sera Prognostics reports financial results in USD
      What is the latest annual turnover for Sera Prognostics?
      The latest annual turnover of Sera Prognostics is USD 306k
      What is the latest annual profit for Sera Prognostics?
      The latest annual profit of Sera Prognostics is USD -36.24M
      What is the registered address of Sera Prognostics?
      The registered address for Sera Prognostics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Sera Prognostics website address?
      The website address for Sera Prognostics is www.seraprognostics.com
      Which industry sector does Sera Prognostics operate in?
      Sera Prognostics operates in the MEDICAL LABORATORIES sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      KTTAPasithea Therapeutics Corporation
      $ 3.42
      (64.42%)
      		17.04M
      ESCAEscalade Inc
      $ 24.60
      (64.11%)
      		451
      OPOFOld Point Financial Corporation
      $ 39.51
      (58.99%)
      		6
      TWINTwin Disc Inc
      $ 17.88
      (58.93%)
      		228
      ADSEADD TEC Energy PLC
      $ 23.39
      (56.66%)
      		18
      SBFGSB Finanical Group Inc
      $ 12.22
      (-46.85%)
      		10
      THRYThryv Holdings Inc
      $ 10.01
      (-46.01%)
      		4
      AURAAura Biosciences Inc
      $ 5.01
      (-37.38%)
      		4
      LSBKLake Shore Bancorp Inc
      $ 11.01
      (-30.23%)
      		1
      INBXInhibrx Biosciences Inc
      $ 9.01
      (-30.21%)
      		30
      CYNCYNGN Inc
      $ 0.1035
      (45.77%)
      		185.52M
      RIMEAlgorhythm Holdings Inc
      $ 0.0205
      (-15.98%)
      		51.78M
      SXTP60 Degrees Pharmaceuticals Inc
      $ 0.7048
      (18.06%)
      		27.91M
      UPCUniverse Pharmaceuticals Inc
      $ 0.237
      (-12.19%)
      		23.74M
      KTTAPasithea Therapeutics Corporation
      $ 3.41
      (63.94%)
      		17.05M

      SERA Discussion

      View Posts
      glenn1919 glenn1919 12 months ago
      SERA.................................https://stockcharts.com/h-sc/ui?s=SERA&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 1 year ago
      SERA.............................https://stockcharts.com/h-sc/ui?s=SERA&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 1 year ago
      SERA...............................https://stockcharts.com/h-sc/ui?s=SERA&p=W&b=5&g=0&id=p86431144783
      👍️0
      MiamiGent MiamiGent 1 year ago
      Looking back, SERO had the best news this morning

      $7.81 +5.71 (+271.91%)

      BRIEF-Sera Prognostics Announces Primary Endpoint Criteria Met In Pivotal Prime Study Interim Look - Enrollment To Stop Due To Success
      REUTERS 8:40 AM ET Dec-06-2023
      Dec 6 (Reuters) - Sera Prognostics Inc (SERA.NaE):

      * SERA PROGNOSTICS ANNOUNCES PRIMARY ENDPOINT CRITERIA MET IN PIVOTAL PRIME STUDY INTERIM LOOK - ENROLLMENT TO STOP DUE TO SUCCESS Source text for Eikon: Further company coverage:
      👍️0

      Your Recent History

      NASDAQ
      SERA
      Sera Prognostics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads